We review the beginning of COVID vaccination in general practice and the latest pandemic research.
The national vaccine rollout moved into phase 1b this week, but floods along the east coast of Australia created problems for GP deliveries.
Meanwhile, Australian pharmaceutical/biotechnology companies CSL-Behring and Seqirus received the green light from the Therapeutic Goods Administration for the local manufacturing of the AstraZeneca/Oxford vaccine.
This episode we catch up with TMR’s resident COVID blogger Bianca Nogrady to discuss the vaccine rollout and what the latest COVID-19 research tells us.
You can also listen and subscribe to the show by searching for “The Tea Room Medical Republic” in your favourite podcast player.
